| |
| |
|
| Insider
Information: |
Rosenblum Mark J |
| Relationship: |
Exec VP Finance, CFO |
| City: |
Dallas |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
428,859 |
|
|
Indirect Shares
|
686,275 |
|
|
| Direct
Value |
$20,313 |
|
|
|
Indirect Value
|
$42,549 |
|
|
| Total
Shares |
1,115,134 |
|
|
| Total
Value |
$62,862 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hemobiotech Inc |
HMBT |
Chief Financial Officer |
2009-03-04 |
293,234 |
2005-11-21 |
0 |
Premium* |
|
|
Advaxis Inc |
ADXS |
Chief Financial Officer |
2014-01-31 |
113,774 |
2012-05-14 |
686,275 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
Exec VP Finance, CFO |
2023-02-13 |
21,851 |
2020-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,432 |
21,851 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
15,419 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2022-11-03 |
4/A |
A |
$1.73 |
$2,580 |
D/D |
1,488 |
7,419 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2022-11-03 |
4/A |
A |
$1.73 |
$12,682 |
D/D |
7,314 |
13,245 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2022-11-03 |
4 |
A |
$1.73 |
$12,682 |
D/D |
7,314 |
155,633 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2022-05-31 |
4 |
B |
$0.18 |
$5,040 |
D/D |
28,000 |
148,319 |
2.74 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2022-05-03 |
4 |
A |
$0.19 |
$1,863 |
D/D |
10,000 |
120,319 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2022-03-03 |
4 |
B |
$0.39 |
$29,812 |
D/D |
76,246 |
110,319 |
2.74 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2021-11-03 |
4 |
A |
$0.72 |
$5,591 |
D/D |
7,787 |
34,073 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2021-05-03 |
4 |
A |
$0.57 |
$5,422 |
D/D |
9,563 |
26,286 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2020-11-03 |
4 |
A |
$0.56 |
$2,650 |
D/D |
4,723 |
16,723 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2020-08-17 |
4 |
B |
$1.00 |
$5,000 |
D/D |
5,000 |
12,000 |
2.74 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2020-02-19 |
4 |
B |
$0.95 |
$1,900 |
D/D |
2,000 |
7,000 |
2.66 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Exec VP Finance, CFO |
• – – |
2020-02-13 |
4 |
B |
$0.86 |
$4,295 |
D/D |
5,000 |
5,000 |
2.66 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2014-01-31 |
4 |
D |
$4.49 |
$216 |
D/D |
(48) |
113,774 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
530 |
113,822 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2014-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,985 |
23,181 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2014-01-07 |
4 |
D |
$4.03 |
$6,307 |
D/D |
(1,565) |
21,616 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2014-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
121,616 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2014-01-07 |
4 |
D |
$4.03 |
$33,546 |
D/D |
(8,324) |
113,292 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Financial Officer |
• – – |
2013-10-24 |
4 |
B |
$4.00 |
$48,000 |
D/D |
12,000 |
20,196 |
2.74 |
- |
|
| ADXS |
Advaxis Inc |
CFO, SVP and Secretary |
• – – |
2012-05-14 |
4 |
A |
$0.00 |
$0 |
I/I |
686,275 |
686,275 |
0 |
- |
|
| HMBT |
Hemobiotech Inc |
Chief Financial Officer |
• – – |
2009-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
293,234 |
0 |
- |
|
| HMBT |
Hemobiotech Inc |
Chief Financial Officer |
• – – |
2005-11-21 |
4 |
B |
$1.50 |
$3,000 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
